General Information of the Compound
| Compound ID |
CP0573798
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[3-[(3S,6S,9S,12R,15S)-9-(3-aminopropyl)-12-[(4-hydroxyphenyl)methyl]-7-methyl-3-(naphthalen-2-ylmethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]propyl]guanidine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C39H51N9O6
|
||||||||||||||||||
| Molecular Weight |
741.894
|
||||||||||||||||||
| Canonical SMILES |
CN1[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C39H51N9O6/c1-47-32(10-5-19-43-39(41)42)35(51)46-31(23-25-12-15-26-7-2-3-8-27(26)21-25)38(54)48-20-6-11-33(48)36(52)45-30(22-24-13-16-28(49)17-14-24)34(50)44-29(37(47)53)9-4-18-40/h2-3,7-8,12-17,21,29-33,49H,4-6,9-11,18-20,22-23,40H2,1H3,(H,44,50)(H,45,52)(H,46,51)(H4,41,42,43)/t29-,30+,31-,32-,33-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
HRAWNHBGQQZVKN-WUXKFAKNSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04108, Atypical chemokine receptor 3
Protein ID: PT02059, C-X-C chemokine receptor type 4